SCHEMBL28355178

SCHEMBL28355178

CCCc1cc(O)c(OC)cc1CC(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 2/20 0.60
GAA P10253 3/20 0.50
ALDH1A1 P00352 2/20 0.50
TSHR P16473 2/20 0.50
NFKB1 P19838 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
HSD17B10 Q99714 1/20 0.46
KDM4E B2RXH2 2/20 0.43
POLB P06746 2/20 0.43
ABL1 P00519 1/20 0.43
MAPT P10636 1/20 0.43
RECQL P46063 1/20 0.43
RIN1 Q13671 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PTPN1 P18031 1/20 0.41
PTPN11 Q06124 1/20 0.41
TRPV1 Q8NER1 3/20 0.40
CYP3A4 P08684 2/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31317789 0.82 HMGCR (0.65) HMGCRALDH1A1TSHRKDM4EMAPT
SCHEMBL3833716 0.82 GAA (0.57) HMGCRGAAALDH1A1TSHRNFKB1
SCHEMBL26615249 0.82 HMGCR (0.65) HMGCRALDH1A1TSHRKDM4EMAPT
SCHEMBL20399527 0.82 HMGCR (0.65) HMGCRALDH1A1TSHRKDM4EMAPT
SCHEMBL16109698 0.79 HSD17B10 (0.61) HMGCRGAAALDH1A1TSHRNFKB1
SCHEMBL12904365 0.79 GAA (0.54) HMGCRGAAALDH1A1TSHRNFKB1
SCHEMBL15760015 0.78 HSD17B10 (0.57) HMGCRGAAALDH1A1TSHRNFKB1
SCHEMBL11793593 0.78 HMGCR (0.81) HMGCRALOX5GABRA1GABRB2
SCHEMBL2729269 0.78 GAA (0.53) HMGCRGAAALDH1A1TSHRNFKB1
SCHEMBL4023259 0.78 GAA (0.53) HMGCRGAAALDH1A1TSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110790652-A Imatinib intermediate, synthetic method thereof and intermediate 南京红杉生物科技有限公司 2020-02-14 CN claimed
CN-110790652-A Imatinib intermediate, synthetic method thereof and intermediate 南京红杉生物科技有限公司 2020-02-14 CN disclosed
CN-110790652-A Imatinib intermediate, synthetic method thereof and intermediate 南京红杉生物科技有限公司 2020-02-14 CN disclosed